
Early-stage venture fund taking science and engineering research from labs to market

Life sciences venture fund investing in early-stage biomedical projects around the world

RBV Capital is a venture capital fund dedicated to life sciences, set up in 2014. It puts money into early-stage biomedical projects across the globe and aims to build a spread of breakthrough assets.
The fund works with early-stage life sciences companies worldwide. Its site separates current investments, exited investments and the wider portfolio.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about RBV Capital.
Similar listings buyers compare against this one.

Early-stage venture fund taking science and engineering research from labs to market

Investment manager backing early-stage cannabis and other emerging-industry companies for institutional investors

Quark Venture Capital

Zencap Asset Management

Oslo-based private investment company backing early and later-stage life science businesses

Life science investor putting money into young oncology and genetic disease drug developers
Everything here links back to the same verified catalogue. Pick your next stop.